AOP Orphan reports full validity of arbitral award against PharmaEssentia
Vienna (pts027/25.03.2021/13:50) – Today the Higher Regional Court of Frankfurt declared
Vienna (pts027/25.03.2021/13:50) – Today the Higher Regional Court of Frankfurt declared
Vienna (pts022/15.03.2021/13:45) – The US Food & Drug Administration (FDA) issued
Vienna (pts018/01.02.2021/12:25) – Development and clinical data from the European Healthcare
Vienna, Austria (pts026/26.01.2021/12:55) – The Austrian pharmaceutical company AOP Orphan
Vienna, Austria (pts001/07.12.2020/00:00) – Ropeginterferon alfa-2b showed clear advantages in efficacy